Skip to contentY
Yarrow Bioscience, Inc.
Y
YARWYarrow Bioscience, Inc. Released Mar 28, 2018, after the close
10-K filed Mar 28, 2018, 87 days after period end · 0001628280-18-003726
Q4 2017 · 10-K
Revenue$2.78M$2.78Mno prior Q4 2016 on file+205.3% vs Q3 2017 Net Income-$9.28M-$9.28M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Yarrow Bioscience, Inc. · CIK 1566044 · Engraved from SEC EDGAR
N/M vs Q3 2017
EPS Diluted-$1.80-$1.80N/M vs Q4 2016N/M vs Q3 2017 Operating Incomederived-$9,478,000— Operating Cash Flowderived-$10,157,000— Free Cash Flowderived-$10,169,000— Margins · derivedOperating margin-341.5%
Net margin-334.3%
ended Dec 31, 2017 · filed Mar 28, 2018 · 87 d after period end